Spain Brazil Russia France Germany China Korea Japan

Artificial Intelligence driven Marketing Communications

Sep 13, 2019 9:42 AM ET

Diabetes Drugs Market Growth, Increase CAGR by Top Key Players like Johnson & Johnson, Bayer Pharmaceuticals, Novo Nordisk till 2026

Diabetes Drugs Market Growth, Increase CAGR by Top Key Players like Johnson & Johnson, Bayer Pharmaceuticals, Novo Nordisk till 2026

iCrowd Newswire - Sep 13, 2019

The Global Diabetes Drugs Market is expected to reach US$ 78,261.7 mn by 2026 owing to rising prevalence of diabetes the world over. Key insights into this growing market have been shared by Fortune Business Insights in its report, titled “Diabetes Drugs Market Size, Share and Global Trend By Drug Class (Insulin, DPP-4 Inhibitors, GLP-1 Receptor Agonists, SGLT2 Inhibitors), Diabetes Type (Type 1, Type 2), Route of Administration (Oral, Subcutaneous, Intravenous), Distribution Channel (Online pharmacies, Hospital Pharmacies, Retail Pharmacies) and Geography Forecast till 2026”.

Browse Complete Report Details @

Some of the Main Key Players Covered in the Diabetes Drugs Market Report

North America Expected to Dominate the Market

North America is expected to hold a large chunk of the Diabetes Drugs Market share in the forecast period. This evaluation is based on the region’s revenue generation of USD 23,965.5 million in 2018. Moreover, rising prevalence of diabetes in the US is encouraging companies to develop novel and affordable drugs for the patients.

Get Sample PDF Brochure @

Growing awareness among the people regarding diabetes and anti-diabetic drugs in North America will aid growth of the global diabetes drugs market , North America is expected to be followed by Europe in terms of market share and revenue generation during the forecast period

Key Segmentation for Diabetes Drugs Market

By Drug Class

By Diabetes Type

By Route of Administration

By Distribution Channel

By Geography

Rising Demand for Insulin Treatments to Surge the Market

Insulin provides the one of the most efficient treatment methods for diabetes. As a result, there is a growing demand for low-cost insulin treatments, especially to combat Type 2 diabetes. The rapidly rising insulin segment is, therefore, expected to boost the global diabetes drugs market during the forecast period. This has also encouraged private and public investments in research and development, which, in turn, will accelerate diabetes drugs market growth. For example, recently, a rapid-acting, low-cost insulin called Lispro was launched in its generic form by Eli Lilly and Company in the US.

Market Competition Set to Intensify

Key players are increasing their investments in research and development activities and launching new products to maintain their competitive edge. For example, in July 2019, the National Institute for Health and Care Excellence cleared Forxiga for treating Type 1 diabetes in England and Wales. The drug has been developed jointly by Bristol-Myers Squibb and AstraZeneca. The global diabetes drug market is expected to grow as a result.

Fortune Business Insights identifies some key players in the Diabetes Drugs Market which include Johnson and Johnson Services, Eli Lilly and Company, AstraZeneca, Novartis AG, Novo Nordisk A/S, Boehringer Ingelheim International GmbH, Sanofi, and a few others.

Major Table of Content for Diabetes Drugs Market:

1. Introduction

1.1. Research Scope

1.2. Market Segmentation

1.3. Research Methodology

1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

3.1. Market Drivers

3.2. Market Restraints

3.3. Market Opportunities

4. Key Insights

4.1 Prevalence of Diabetes – For Key Countries, 2018

4.2 Pipeline Analysis

4.3 Key Industry Developments Mergers, Acquisitions and Partnerships

4.4 Introduction of New Drugs/Approvals (by major players)

4.5 Overview of Regulatory Scenario of Key Countries/ Regions

More Trending Topics from Fortune Business Insights:

Wound Care Devices Market to Value US$ 2,949.2 Mn at CAGR of 5.1% by 2025 | Exclusive Report by Fortune Business Insights

Dental Implants Market to Value US$ 5725.7 Mn at CAGR of 5.1% by 2026 | Exclusive Report by Fortune Business Insights

Implantable Cardioverter Defibrillator Market to reach US$ 8,343.4 Mn by 2026, Medtronic Leads the Market with Increasing Customer Reach, says Fortune Business Insights

About Us:

Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights, we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Press Release Distributed by The Express Wire

To view the original version on The Express Wire visit Diabetes Drugs Market Growth, Increase CAGR by Top Key Players like Johnson & Johnson, Bayer Pharmaceuticals, Novo Nordisk till 2026


Tags:    Wire, Research Newswire, English